PD35-12 ASSOCIATION BETWEEN USE OF SECOND-GENERATION ANTIANDROGENS AND OVERALL SURVIVAL IN PATIENTS WITH METASTATIC PROSTATE CANCER – A POPULATION-BASED STUDY. (1st May 2022)